Dr Reddys Laboratories RDY
NYSE RDY
$13.10 +0.03 (+0.23%)
As of: Oct 19, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Total Debt (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) recorded Total Debt of $785.15 million in the quarter ended Jun 30, 2026, up 54.3% from $508.85 million a year earlier but down 13.9% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Total Debt (2009 - 2026) Analysis & Trends

As of Mar 31, 2026, Dr Reddys Laboratories reported Total Debt of $824 million, up 50.6% from the prior year.

  • Annual Total Debt has a five-year compound annual growth rate of 14.8% (years ended Mar 2021 to Mar 2026).
  • Across earlier years, Total Debt came in at $547 million in the year ended Mar 31, 2025 (+127.0%), $241 million in the year ended Mar 31, 2024 (-22.8%), $312 million in the year ended Mar 31, 2023 (-30.0%) and $446 million in the year ended Mar 31, 2022 (+7.7%).
  • Quarterly Total Debt has ranged from $163.88 million in the quarter ended Mar 31, 2023 to $911.71 million in the quarter ended Mar 31, 2026 over the past five years.
  • On a year-over-year basis, Total Debt has increased for ten consecutive quarters, with growth averaging 90.1% over the last eight quarters.
  • Peak year-over-year performance for Total Debt in the last five years was growth of 228.7% in the quarter ended Sep 30, 2024, against a decline of 63.6% in the quarter ended Mar 31, 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $911.71 million (quarter ended Mar 31, 2026), $826.15 million (quarter ended Dec 31, 2025) and $671.13 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn 49.04 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn 70.82 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn 32.35 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn 26.25 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn 63.19 Bn
10 Dr Reddys Laboratories 10.90 Bn 10.27 Bn 396.53 Mn 784.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 784.17 Mn
Mar 31, 2026 819.67 Mn
Dec 31, 2025 819.54 Mn
Sep 30, 2025 659.93 Mn
Jun 30, 2025 629.70 Mn
Mar 31, 2025 546.72 Mn
Dec 31, 2024 608.38 Mn
Sep 30, 2024 579.28 Mn
Jun 30, 2024 382.93 Mn
Mar 31, 2024 240.07 Mn
Dec 31, 2023 257.67 Mn
Sep 30, 2023 175.04 Mn
Jun 30, 2023 166.21 Mn
Mar 31, 2023 164.09 Mn
Dec 31, 2022 270.43 Mn
Sep 30, 2022 270.09 Mn
Jun 30, 2022 374.25 Mn
Mar 31, 2022 446.34 Mn
Dec 31, 2021 389.14 Mn
Sep 30, 2021 419.65 Mn
API Access

Dr Reddys Laboratories Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=RDY&period=max&api_key=YOUR_API_KEY